Endomorphin-1, an endogenous μ-opioid receptor agonist, improves apomorphine-induced impairment of prepulse inhibition in mice
Authors:
- Makoto UkaiMUMakoto Ukai
- Ami OkudaAOAmi Okuda
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 19 references indexed in Scilit:
- Endomorphin-1 improves scopolamine-induced impairment of short-term memory via μ1-opioid receptor in miceNeuroReport, 2001
- Endomorphins 1 and 2, endogenous μ-opioid receptor agonists, impair passive avoidance learning in miceEuropean Journal of Pharmacology, 2001
- A potent and selective endogenous agonist for the µ-opiate receptorNature, 1997
- Opioid Receptor Agonists Selective for .MU. and .KAPPA. Receptors Attenuate Methamphetamine-Induced Behavioral Sensitization in the Mouse.Biological and Pharmaceutical Bulletin, 1996
- Receptor-selective opioid peptides fail to affect behavioral responses induced by a low dose of apomorphine in the mousePharmacology Biochemistry and Behavior, 1993
- [D-Ala2, NMePhe4,Gly-ol 5]enkephalin, but not [D-Pen2,L-Pen5]enkephalin, specifically behaviors by the D2 RU 24213European Journal of Pharmacology, 1991
- DAGO ([d-Ala2,N-Me-Phe4,Gly-ol]enkephalin) specifically reverses apomorphine-induced increase in rearing and grooming behaviors in the mouseBrain Research, 1991
- Neuropeptides, Dopamine, and SchizophreniaaAnnals of the New York Academy of Sciences, 1988
- Naloxonazine actions in vivoEuropean Journal of Pharmacology, 1986
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980